Tuberculosis Surveillance and Control Program Flashcards
elements of the TB Control Program
TB screening preventive therapy TB case identification TB patient management Contact investigation
Tuberculin Skin Test method name
Mantoux Method
two products in PPD test
Tubersol-preferred product
Aplisol-alternate product
what is mycobacterium tuberculosis
bacteria that causes latent TB infection and active TB disease,
treatment for LTBI
Isoniazid (INH) and Rifapentine (RPT) in an oral weekly does of 15mg, of INH and RPT based off weight 10-14 kg, 300mg, 14.1-25.0kg, 450 ,g 25.1-32.0kg 600mg, 32.1-49.9 kg 750 mg. 750> 900mg max for 3 months.
alternate regiment for LTBI
Rifampin (RIF) oral daily dose of 10mg (600 max) for 4 months.
INH + RIF oral dsialy dose of 5mg and 10mg respectively, for 3 months
required provided documentation for CIVMAR/MSC when past exposure or positive test
clinical evaluations
hospitalizations
diagnosis
treatments
induration of 5 mm or greater is considered high risk with the following people
recent contacts of active TB disease patients
persons with fibriotic changes
patients suspected of having active TB
induration of 10mm or greater is considered positive, medium risk for the following
recent immigrants (w in 5 years) from high Tb areas
healthcare workers
people with clinical
people of low risk with induration of this size are considered positive
15 mm
how much ml is put in the syringe for mantoux method of PPD testing
.1ml